Literature DB >> 7712615

Pathology of AIDS-related liver disease.

J H Lefkowitch1.   

Abstract

Hepatomegaly and abnormalities of serum liver tests are common problems in patients with acquired immune deficiency syndrome. Opportunist infections (Mycobacterium avium-intracellulare and cytomegalovirus) and neoplasms (lymphoma, Kaposi's sarcoma) are among the most prevalent hepatic lesions in AIDS. Although Kupffer cells and endothelial cells are potential sites of human immunodeficiency virus 1 (HIV-1) infection, current studies do not indicate that the liver is a major reservoir for this virus. Drug hepatotoxicity, multimicrobial infections of the biliary tree resembling sclerosing cholangitis and a variety of nonspecific hepatic changes should be considered in evaluating AIDS patients or HIV-1-infected patients with evidence of liver dysfunction.

Entities:  

Mesh:

Year:  1994        PMID: 7712615     DOI: 10.1159/000171468

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

Review 1.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

2.  HIV infection increases HCV-induced hepatocyte apoptosis.

Authors:  Jae Young Jang; Run-Xuan Shao; Wenyu Lin; Ethan Weinberg; Woo Jin Chung; Wei Lun Tsai; Hong Zhao; Kaku Goto; Leiliang Zhang; Jorge Mendez-Navarro; Nikolaus Jilg; Lee F Peng; Mark A Brockman; Raymond T Chung
Journal:  J Hepatol       Date:  2010-09-29       Impact factor: 25.083

3.  Low-level HIV infection of hepatocytes.

Authors:  Ling Kong; Walter Cardona Maya; Maria E Moreno-Fernandez; Gang Ma; Mohamed T Shata; Kenneth E Sherman; Claire Chougnet; Jason T Blackard
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

4.  TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.

Authors:  Stacey A Rizza; Kishore B Challagundla; Sekar Natesampillai; Gary D Bren; Jaromir Sykora; Henning Walczak; Andrew D Badley
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

5.  Liver Enzymes Abnormalities among Highly Active Antiretroviral Therapy Experienced and HAART Naïve HIV-1 Infected Patients at Debre Tabor Hospital, North West Ethiopia: A Comparative Cross-Sectional Study.

Authors:  Melashu Balew Shiferaw; Ketema Tafess Tulu; Amtatachew Moges Zegeye; Amarech Asratie Wubante
Journal:  AIDS Res Treat       Date:  2016-07-14

6.  Prevalence and predictors of liver disease in HIV-infected children and adolescents.

Authors:  Maria Pokorska-Śpiewak; Aleksandra Stańska-Perka; Jolanta Popielska; Agnieszka Ołdakowska; Urszula Coupland; Konrad Zawadka; Małgorzata Szczepańska-Putz; Magdalena Marczyńska
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

7.  Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV/HCV infection: an 11-year retrospective cohort study in Guangxi, China.

Authors:  Fengxiang Qin; Junjun Jiang; Chunwei Qin; Yunxuan Huang; Bingyu Liang; Yuexiang Xu; Jiegang Huang; Zhiliang Xu; Chuanyi Ning; Yanyan Liao; Ning Zang; Jingzhen Lai; Wudi Wei; Jun Yu; Li Ye; Xionglin Qin; Hao Liang
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

8.  HIV induces TRAIL sensitivity in hepatocytes.

Authors:  Challagundla K Babu; Kanitta Suwansrinon; Gary D Bren; Andrew D Badley; Stacey A Rizza
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.